1,011 results match your criteria Menopause and Mood Disorders


Objective and subjective vasomotor symptom outcomes in the CBT-Meno randomized controlled trial.

Climacteric 2020 Apr 17:1-7. Epub 2020 Apr 17.

Department of Psychiatry and Behavioral Neurosciences, McMaster University, Hamilton, ON, Canada.

Vasomotor symptoms (hot flashes, night sweats) are common during the menopausal transition. Pharmacotherapy is effective but is associated with health risks for some women. There is an increasing demand for non-pharmacological interventions. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/13697137.2020.1737929DOI Listing

Executive function after risk-reducing salpingo-oophorectomy in BRCA1 and BRCA2 mutation carriers: does current mood and early life adversity matter?

Menopause 2020 Jul;27(7):746-755

Department of Psychiatry, Anschutz Medical Campus, University of Colorado, Aurora, CO.

Objective: Despite the fact that negative mood and executive dysfunction are common after risk-reducing salpingo-oophorectomy (RRSO), occurring in up to a third of women, little is known about risk factors predicting these negative outcomes. Adverse childhood experiences (ACE) predict poorer health in adulthood and may be a risk factor for negative outcomes after RRSO. Given the complex relationship between early life stress, affective disorders, and cognitive dysfunction, we hypothesized that ACE would be associated with poorer executive function and that mood symptoms would partially mediate this relationship. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/GME.0000000000001535DOI Listing

FSH signaling is involved in affective disorders.

Biochem Biophys Res Commun 2020 May 11;525(4):915-920. Epub 2020 Mar 11.

Department of Endocrinology, Shandong Provincial Hospital Affiliated to Shandong University, Ji-nan, 25000, China; Shandong Provincial Key Laboratory of Endocrinology and Lipid Metabolism, Ji-nan, 25000, China; Institute of Endocrinology and Metabolism, Shandong Academy of Clinical Medicine, Medicine, Ji-nan, 25000, China; School of Medicine, Shandong University, Ji-nan, 25000, China; Department of Endocrinology, Shandong Provincial Hospital Affiliated to Shandong First Medical University & Shandong Academy of Medical Sciences, Ji-nan, 25000, China. Electronic address:

Affective disorders are a set of mental disorders and particularly disrupt the mental health of susceptible women during puberty, pregnancy, parturition and menopause transition, which are characterized by dramatic changes in reproductive hormone profiles. The serum FSH level changes significantly during these periods; yet, the role of FSH in mood regulation is poorly understood. In the current study, FSHR knockout (Fshr) mice displayed enhanced affective disorder behaviors in an open field test and a forced swim test, accompanied by altered gene expression profiles. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbrc.2020.03.039DOI Listing

Clinical Effects of Early or Surgical Menopause.

Obstet Gynecol 2020 Apr;135(4):853-868

Department of Obstetrics and Gynecology, University Hospitals of Cleveland, MacDonald Women's Hospital, Case Western Reserve University School of Medicine, Cleveland, and Ms. Medicine, Cincinnati, Ohio.

Increasing numbers of women experience early menopause due in part to surgical treatment for benign gynecologic disorders and the rise in risk-reducing bilateral salpingo-oophorectomy in women with BRCA mutations. Unfortunately, the adverse health consequences of early loss of ovarian function accelerate the menopausal state and affect multiple systems, including cardiovascular, neurologic, bone, and connective tissue, and affect quality of life owing to vasomotor symptoms, mood, sleep, and sexual function. Yet many clinicians and women remain reluctant to use hormone therapy because of the Women's Health Initiative's adverse findings, even though they are not applicable to women with early menopause. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/AOG.0000000000003729DOI Listing

Towards improving recognition and management of perimenopausal depression.

Authors:
Barbara L Parry

Menopause 2020 04;27(4):377-379

University of California, San Diego, CA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/GME.0000000000001519DOI Listing

Avocado-Soybean Unsaponifiables: A Panoply of Potentialities to Be Exploited.

Biomolecules 2020 01 13;10(1). Epub 2020 Jan 13.

Faculty of Medicine, University of Porto, Alameda Prof. Hernâni Monteiro, 4200-319 Porto, Portugal.

Avocado and soybean unsaponifiables (ASU) constitute vegetable extracts made from fruits and seeds of avocado and soybean oil. Characterized by its potent anti-inflammatory effects, this ASU mixture is recommended to act as an adjuvant treatment for osteoarthritic pain and slow-acting symptomatic treatment of hip and knee osteoarthritis; autoimmune diseases; diffuse scleroderma and scleroderma-like states (e.g. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3390/biom10010130DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7023362PMC
January 2020

Effect of symptoms of climacteric syndrome, depression and insomnia on self-rated work ability in peri- and post-menopausal women in non-manual employment.

Ann Agric Environ Med 2019 Dec 7;26(4):600-605. Epub 2019 Nov 7.

Institute of Statistics and Demography, Collegium of Economic Analysis, SGH School of Economics, Warsaw, Poland.

Objective: The aim of the study was evaluation of the relationship between severity of symptoms of climacteric syndrome, depressive disorders and sleep problems, and the self-rated work ability of peri-menopausal and post-menopausal women in non-manual employment.

Material And Methods: The study included 287 women aged 45-60 years, employed in various institutions as non-manual workers. Work Ability Index, Greene Climacteric Scale, Beck Depression Inventory, and Athens Insomnia Scale were used. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.26444/aaem/112838DOI Listing
December 2019

Manualized cognitive behavioral group therapy to treat vasomotor symptoms for women diagnosed with mood disorders.

J Psychosom Res 2020 01 20;128:109882. Epub 2019 Nov 20.

Department of Psychiatry, Case Western Reserve University School of Medicine, Neurological and Behavioral Outcomes Center, University Hospitals Cleveland Medical Center, Cleveland, OH, USA. Electronic address:

Objective: This 6-week, prospective, single-arm study examined the feasibility, acceptability, and preliminary efficacy of cognitive behavioral group therapy in peri- and postmenopausal women with mood disorders (major depression or bipolar) and problematic vasomotor menopausal symptoms.

Methods: 59 participants from an outpatient clinic with mood disorders and problematic vasomotor symptoms were enrolled. The primary outcomes were change from baseline to 6 weeks in Hot Flush Night Sweat Problem Rating, Hot Flash Related Daily Interference, and Quality of Life. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jpsychores.2019.109882DOI Listing
January 2020
2.736 Impact Factor

The allopregnanolone to progesterone ratio across the menstrual cycle and in menopause.

Psychoneuroendocrinology 2020 02 14;112:104512. Epub 2019 Nov 14.

Neuroendocrine Unit, Massachusetts General Hospital/Harvard Medical School, Boston, MA, USA. Electronic address:

The neuroactive steroid 3α-5α-tetrahydroprogesterone (allopregnanolone), a metabolite of progesterone, is a positive allosteric modulator of GABA receptors, and low levels have been implicated in the etiology of mood disorders. However, it is not known whether metabolism of progesterone to allopregnanolone varies across the menstrual cycle or is low after menopause. We hypothesized that the allopregnanolone/progesterone ratio would decrease from the follicular to luteal phase. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.psyneuen.2019.104512DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6935417PMC
February 2020

Management of depressive symptoms in peri- and postmenopausal women: EMAS position statement.

Maturitas 2020 Jan 5;131:91-101. Epub 2019 Nov 5.

Second Department of Obstetrics and Gynecology, Aretaieio Hospital, Medical School, National and Kapodistrian University of Athens, Greece.

Introduction: Globally, the total number of people with depression exceeds 300 million, and the incidence rate is 70 % greater in women. The perimenopause is considered to be a time of increased risk for the development of depressive symptoms and major depressive episodes.

Aim: The aim of this position statement is to provide a comprehensive model of care for the management of depressive symptoms in perimenopausal and early menopausal women, including diagnosis, treatment and follow-up. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.maturitas.2019.11.002DOI Listing
January 2020

An integrated approach to diagnosing and managing sleep disorders in menopausal women.

Maturitas 2019 Oct 28;128:1-3. Epub 2019 Jun 28.

Division of Obstetrics and Gynecology, Department of Clinical and Experimental Medicine, University of Pisa, Italy. Electronic address:

Sleep disorders increase in prevalence during the menopausal transition and they constitute a complex phenomenon. Insomnia, the main sleep disorder, can be a primary disorder or it can be secondary to hot flushes (HF), mood disorders, psychosocial factors, medical conditions, and other sleep disturbances, such as obstructive sleep apnoea (OSA) or restless legs syndrome (RLS). Menopausal women complaining of persistent sleep disorders should be referred to a sleep specialist for comprehensive sleep management because unrecognized and untreated sleep disorders can have dramatic health-related consequences. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.maturitas.2019.06.008DOI Listing
October 2019
4 Reads

Italian Association of Sleep Medicine (AIMS) position statement and guideline on the treatment of menopausal sleep disorders.

Maturitas 2019 Nov 15;129:30-39. Epub 2019 Aug 15.

Division of Obstetrics and Gynecology, Department of Clinical and Experimental Medicine, University of Pisa, Italy.

Insomnia, vasomotor symptoms (VMS) and depression often co-occur after the menopause, with consequent health problems and reductions in quality of life. The aim of this position statement is to provide evidence-based advice on the management of postmenopausal sleep disorders derived from a systematic review of the literature. The latter yielded results on VMS, insomnia, circadian rhythm disorders, obstructive sleep apnea (OSA) and restless leg syndrome (RLS). Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.maturitas.2019.08.006DOI Listing
November 2019
5 Reads

Group cognitive behavioural therapy of physical and psychological menopausal symptoms of Chinese women, delivered via Internet and mobile phone versus face to face: A protocol for a randomized non-inferiority trial.

Maturitas 2019 Nov 13;129:23-29. Epub 2019 Aug 13.

Southeast University, China. Electronic address:

Background: Menopause syndrome generally includes psychological problems. Group treatment delivered via the Internet and mobile phone (imGT) may improve women's physiological and psychological conditions.

Objective: To investigate the efficacy of group cognitive behavioural therapy of menopause-related mood swings and quality of life, delivered face to face or via the Internet and mobile phone. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.maturitas.2019.08.005DOI Listing
November 2019
2 Reads
2.942 Impact Factor

Psychosomatic and vasomotor symptom changes during transition to menopause.

Prz Menopauzalny 2019 Jun 28;18(2):110-115. Epub 2019 Jun 28.

2 Department of Obstetrics and Gynaecology, University of Athens Medical School, Athens, Greece.

Menopause is the condition in which the gradual decline in ovarian function finally leads to the permanent cessation of menstruation. Oestrogen deficiency may cause early symptoms during the menopausal transition and late symptoms after menopause. Menopause is a normal period of life. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5114/pm.2019.86835DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6719639PMC
June 2019
1 Read

Mental health conditions diagnosed before bilateral oophorectomy: a population-based case-control study.

Menopause 2019 12;26(12):1395-1404

Division of Epidemiology, Department of Health Sciences Research, Mayo Clinic, Rochester, MN.

Objective: We studied eight mental health conditions diagnosed before bilateral oophorectomy performed for nonmalignant indications.

Methods: We identified 1,653 premenopausal women who underwent bilateral oophorectomy for a nonmalignant indication in Olmsted County, Minnesota, during a 20-year period (1988-2007). Each woman was matched by age (±1 year) to one population-based control who had not undergone bilateral oophorectomy before the index date (age range: 21-49 years). Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/GME.0000000000001413DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6893116PMC
December 2019
5 Reads

A Nutraceutical Approach to Menopausal Complaints.

Medicina (Kaunas) 2019 Aug 28;55(9). Epub 2019 Aug 28.

Department of Women, Child and General and Specialized Surgery, University of Campania "Luigi Vanvitelli", 80138 Naples, Italy.

The menopausal transition, or perimenopause, is characterized by menstrual irregularities, vasomotor symptoms, sleep disturbances, mood symptoms, and urogenital tract atrophy. These changes can also affect the quality of life and one's self-esteem. Hormone replacement therapy (HRT) is considered the best option to achieve therapeutic relief of different menopausal symptoms but is usually restricted to moderate or severe symptoms. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3390/medicina55090544DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6780855PMC
August 2019
2 Reads

Cognitive behavior therapy for menopausal symptoms (CBT-Meno): a randomized controlled trial.

Menopause 2019 09;26(9):972-980

Department of Psychiatry and Behavioural Neurosciences, McMaster University, Hamilton, Ontario, Canada.

Objective: To evaluate the effectiveness of cognitive behavioral therapy for menopausal symptoms (CBT-Meno) compared with a waitlist condition (no active intervention). A randomized controlled trial was conducted with 71 perimenopausal or postmenopausal women who were seeking treatment for menopausal symptoms.

Methods: Blind assessments were conducted at baseline, 12 weeks postbaseline, and 3 months post-treatment. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/GME.0000000000001363DOI Listing
September 2019
8 Reads

Tibolon - the only one member of STEARs group.

Authors:
Tomáš Fait

Cas Lek Cesk 2019 ;158(3-4):107-111

Tibolon is the only therapeutic approach to climacteric symptoms, prevention of osteoporosis and urogenital atrophy with the same efficacy as hormone replacement therapy. Tibolon has more positive effects on sexuality and mood changes in menopausal women. It decreases the mammographic density. Read More

View Article

Download full-text PDF

Source
October 2019
3 Reads

Menstrual Health as a Part of Preventive Health Care.

Obstet Gynecol Clin North Am 2019 Sep;46(3):441-453

Division of Emergency Obstetrics and Gynecology, Department of Obstetrics and Gynecology, Women and Infants Hospital, Warren Alpert Medical School of Brown University, 101 Dudley Street, Providence, RI 02905, USA.

Menstrual health assessment facilitates identification of pathologic conditions (eg, abnormal uterine bleeding, endometriosis), offers the opportunity to educate women on what menstrual symptoms may be normal or abnormal, and provides the opportunity to initiate treatment for women who are suffering because of problems with menstrual bleeding or associated symptoms. Heavy bleeding, pain, fatigue, and mood changes significantly affect a woman's physical, social, and emotional quality of life. Promptly identifying and treating these disorders by incorporating their assessment into routine well-woman care has the potential to positively affect the lives of a substantial number of women. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ogc.2019.04.004DOI Listing
September 2019
1 Read

The Role of Estrogen in Brain and Cognitive Aging.

Neurotherapeutics 2019 07;16(3):649-665

Center for Cognitive Medicine, Department of Psychiatry and Behavioral Sciences, Vanderbilt University Medical Center, Nashville, TN, 37212, USA.

There are 3 common physiological estrogens, of which estradiol (E2) is seen to decline rapidly over the menopausal transition. This decline in E2 has been associated with a number of changes in the brain, including cognitive changes, effects on sleep, and effects on mood. These effects have been demonstrated in both rodent and non-human preclinical models. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s13311-019-00766-9DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6694379PMC
July 2019
4 Reads

Activation of Adrenal Steroidogenesis and an Improvement of Mood Balance in Postmenopausal Females after Spa Treatment Based on Physical Activity.

Int J Mol Sci 2019 Jul 27;20(15). Epub 2019 Jul 27.

Institute of Endocrinology, 11694 Prague, Czech Republic.

Spa treatment can effectively reestablish mood balance in patients with psychiatric disorders. In light of the adrenal gland's role as a crossroad of psychosomatic medicine, this study evaluated changes in 88 circulating steroids and their relationships with a consolidation of somatic, psychosomatic and psychiatric components from a modified N-5 neurotic questionnaire in 46 postmenopausal 50+ women with anxiety-depressive complaints. The patients underwent a standardized one-month intervention therapy with physical activity and an optimized daily regimen in a spa in the Czech Republic. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3390/ijms20153687DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6695846PMC
July 2019
3 Reads

Prevalence and risk factors of sleep disturbances in breast cancersurvivors: systematic review and meta-analyses.

Support Care Cancer 2019 Dec 25;27(12):4401-4433. Epub 2019 Jul 25.

Department of Physiotherapy, Human Physiology and Anatomy, Faculty of Physical Education and Physiotherapy, Vrije Universiteit Brussel, Building F-kine, Laarbeeklaan 103, 1090, Brussels, Belgium.

Background: Breast cancer remains the most frequently diagnosed malignancy among women worldwide, with rising incidence numbers. In Belgium, one out of eight women will be diagnosed with breast cancer. Fortunately, 80% of those breast cancer patients will still be alive 10 years after diagnosis due to improvements in screening and treatment strategies. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00520-019-04936-5DOI Listing
December 2019
2 Reads

Management of Depression in Women.

J Womens Health (Larchmt) 2019 08 23;28(8):1019-1022. Epub 2019 Jul 23.

2Division of Women's Health Internal Medicine, Mayo Clinic, Scottsdale, Arizona.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1089/jwh.2019.7908DOI Listing
August 2019
1 Read

The effect of Hypericum perforatum on postmenopausal symptoms and depression: A randomized controlled trial.

Complement Ther Med 2019 Aug 31;45:109-113. Epub 2019 May 31.

Midwifery Department, Menopause & Andropause Research Center, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.

Objectives: Hypericum perforatum (St John's wort) is an herbal plant that has antidepressant activity and contains ingredients such as flavonols derivatives, bioflavonoids, proanthocyanidins, xanthones, phloroglucinol, and naphthodianthrones. This study was aimed to test the effect of Hypericum perforatum on hot flashes, menopausal symptoms, and depression in postmenopausal women.

Design & Setting: This randomized controlled study was conducted on 80 postmenopausal women aged 45-60 in Izeh, Iran. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ctim.2019.05.028DOI Listing
August 2019
2 Reads

[Possibilities of complex non-drug programs in the correction of psychoemotional disorders of menopause in patients with metabolic syndrome].

Vopr Kurortol Fizioter Lech Fiz Kult 2019 ;96(3):50-59

I.M. Sechenov First Moscow State Medical University, Ministry of Health of Russia, Moscow, Russia.

Background: The problem of ensuring long-term well-being and high quality of life for older women is becoming the most important goal of modern medicine. The initial presence of metabolic syndrome complicates the course of menopause; and menopausal hormone therapy cannot always be used. The urgency for finding the effective ways of non-drug correction of menopausal disorders in this category of patients is obvious. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.17116/kurort20199603150DOI Listing
November 2019
2 Reads

Possible Existence of the Hypothalamic-Pituitary-Hippocampal (HPH) Axis: A Reciprocal Relationship Between Hippocampal Specific Neuroestradiol Synthesis and Neuroblastosis in Ageing Brains with Special Reference to Menopause and Neurocognitive Disorders.

Neurochem Res 2019 Aug 28;44(8):1781-1795. Epub 2019 Jun 28.

School of Life Sciences, Bharathidasan University, Tiruchirappalli, Tamil Nadu, 620024, India.

The hippocampus-derived neuroestradiol plays a major role in neuroplasticity, independent of circulating estradiol that originates from gonads. The response of hypothalamus-pituitary regions towards the synthesis of neuroestradiol in the hippocampus is an emerging scientific concept in cognitive neuroscience. Hippocampal plasticity has been proposed to be regulated via neuroblasts, a major cellular determinant of functional neurogenesis in the adult brain. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11064-019-02833-1DOI Listing
August 2019
11 Reads
2.593 Impact Factor

Insomnia and hot flashes.

Maturitas 2019 Aug 14;126:51-54. Epub 2019 May 14.

Department of Clinical and experimental Medicine, Neurological Clinic, University of Pisa, Italy.

The increased prevalence of sleep disorders associated with menopause has been emphasized by multiple international studies. Many factors are associated with insomnia during menopause, among them: hot flashes (HF), anxiety and depression, other medical conditions, behavioral and psychosocial factors and primitive sleep patterns. The domino hypothesis connects various factors and suggests that HF disturb sleep, thereby causing insomnia, which in turn increases vulnerability to depression. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.maturitas.2019.05.001DOI Listing
August 2019
8 Reads

Sex Differences in Vulnerability and Resilience to Stress Across the Life Span.

Biol Psychiatry 2019 09 7;86(6):421-432. Epub 2019 May 7.

Department of Psychiatry, University of Colorado School of Medicine, Anschutz Medical Campus, Aurora, Colorado.

Susceptibility and resilience to stress depend on 1) the timing of the exposure with respect to development, 2) the time across the life span at which effects are measured, and 3) the behavioral or biological phenotype under consideration. This translational review examines preclinical stress models that provide clues to causal mechanisms and their relationship to the more complex phenomenon of stress-related psychiatric and cognitive disorders in humans. We examine how genetic sex and epigenetic regulation of hormones contribute to the proximal and distal effects of stress at different epochs of life. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.biopsych.2019.04.028DOI Listing
September 2019
9 Reads

Testosterone imbalance may link depression and increased body weight in premenopausal women.

Transl Psychiatry 2019 06 7;9(1):160. Epub 2019 Jun 7.

Department of Neurology, Max Planck Institute for Human Cognitive and Brain Sciences, Leipzig, Germany.

Accumulating evidence supports a link between depression and being overweight in women. Given previously reported sex differences in fat accumulation and depression prevalence, as well as the likely role of sex hormones in both overweight and mood disorders, we hypothesised that the depression-overweight association may be mediated by sex hormones. To this end, we investigated the association of being overweight with depression, and then considered the role of sex hormones in relation to being overweight and depression in a large population-based cohort. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41398-019-0487-5DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6555814PMC
June 2019
9 Reads

Cognitive behavior therapy for menopausal symptoms (CBT-Meno): a randomized controlled trial.

Menopause 2019 May 15. Epub 2019 May 15.

Department of Psychiatry and Behavioural Neurosciences, McMaster University, Hamilton, Ontario, Canada.

Objective: To evaluate the effectiveness of cognitive behavioral therapy for menopausal symptoms (CBT-Meno) compared with a waitlist condition (no active intervention). A randomized controlled trial was conducted with 71 perimenopausal or postmenopausal women who were seeking treatment for menopausal symptoms.

Methods: Blind assessments were conducted at baseline, 12 weeks postbaseline, and 3 months post-treatment. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/GME.0000000000001363DOI Listing
May 2019
39 Reads

Depression and Menopause: An Update on Current Knowledge and Clinical Management for this Critical Window.

Authors:
Claudio N Soares

Med Clin North Am 2019 Jul;103(4):651-667

Department of Psychiatry, Queen's University School of Medicine, 752 King Street West, Kingston, Ontario K7L 4X3, Canada; Research and Innovation, Providence Care Hospital, Kingston, Ontario, Canada. Electronic address:

Windows of vulnerability for depression have been associated with increased sensitivity to hormonal changes experienced by some women during the luteal phase, postpartum, and/or menopause. Increased awareness has resulted in greater adoption of screening tools for mood and behavioral changes and tailored therapies. This article discusses study results and controversies surrounding therapies uniquely designed for menopause-related depression. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.mcna.2019.03.001DOI Listing
July 2019
9 Reads

Neuroendocrine Networks and Functionality.

Authors:
Margaret Altemus

Med Clin North Am 2019 Jul;103(4):601-612

VA Connecticut Health Care System, Women's Clinic, Building 2, Room 7-165, 950 Campbell Avenue, New Haven, CT 06516, USA. Electronic address:

Women undergo developmental and cyclic changes in hormonal exposures that affect brain function and mental health. Some women are more vulnerable to the effects of these hormonal exposures, for reasons that remain to be determined. Evidence to date indicates that anxiety and mood disorders are the most sensitive to hormonal fluctuations in women but there is also growing evidence for a protective effect of female reproductive hormones on schizophrenia. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.mcna.2019.03.003DOI Listing
July 2019
21 Reads

Insomnia and depressive symptoms during the menopausal transition: theoretical and therapeutic implications of a self-reinforcing feedback loop.

Maturitas 2019 May 15;123:78-81. Epub 2019 Feb 15.

Department of Clinical and Experimental Medicine, Psychiatric Section, University of Pisa, Azienda Ospedaliera Universitaria Pisana (AUOP), Pisa, Italy. Electronic address:

Insomnia is a common and recurring condition during the menopausal transition that negatively affects both quality of life and health. Peri-menopausal insomnia has a multifactorial etiology; previous depression, hormonal changes and age/hormone-related irregularity in circadian rhythms can contribute to menopausal insomnia. Age-related poor health, pain and stress may favor the development of insomnia, while vasomotor symptoms, in particular hot flashes, may contribute to chronic forms of insomnia by activating a vicious cycle. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.maturitas.2019.02.007DOI Listing
May 2019
7 Reads
2.942 Impact Factor

The Relationship Between Vitamin D and Postpartum Depression in Reproductive-Aged Iranian Women.

J Med Life 2018 Oct-Dec;11(4):286-292

School of Health Sciences, Health Professions 2239, Central Michigan University, Michigan, United States of America.

The aim of this study was to evaluate the relationship between vitamin D and postpartum depression in reproductive-aged Iranian women. This study was conducted on 120 women (60 with postpartum depression and 60 without) in Izeh, Iran. A socio-demographic questionnaire and Beck Depression Scale were used for data collection. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.25122/jml-2018-0038DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6418338PMC
May 2019
12 Reads

Complementary and Alternative Medicine for Menopause.

J Evid Based Integr Med 2019 Jan-Dec;24:2515690X19829380

1 Baylor University, Waco, TX, USA.

Menopause is associated with problematic symptoms, including hot flashes, sleep problems, mood disorders, sexual dysfunction, weight gain, and declines in cognitive functioning. Many women seek complementary and alternative medicine (CAM) for symptom management. This article critically reviews the existing literature on CAM treatments most commonly used for menopausal symptoms. Read More

View Article

Download full-text PDF

Source
http://journals.sagepub.com/doi/10.1177/2515690X19829380
Publisher Site
http://dx.doi.org/10.1177/2515690X19829380DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6419242PMC
September 2019
28 Reads

Assessment of perimenopausal depression: A review.

J Affect Disord 2019 Apr 11;249:216-222. Epub 2019 Feb 11.

Clinical Psychology and Psychotherapy, University of Zurich, Binzmühlestrasse 14, Zurich 8050, Switzerland; URPP Dynamics of Healthy Aging Research Priority Program, University of Zurich, Zurich, Switzerland. Electronic address:

Background: Within the female life cycle, the perimenopause is considered as a critical period for the development of depression. Prevalence rates are particularly high during this phase. Perimenopausal depression is characterized by affective symptoms as well as menopause-specific somatic complaints. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jad.2019.02.029DOI Listing
April 2019
6 Reads

Acupuncture for perimenopausal depressive disorder: A systematic review and meta-analysis protocol.

Medicine (Baltimore) 2019 Feb;98(7):e14574

Yunnan University of Chinese Medicine, Kunming, Yunnan.

Background: Perimenopausal depressive disorder (PDD) is a disease that plagues many perimenopausal women. There is an urgent need for a safe way to treat the disease. With few side effects, acupuncture treatment for PDD has been gradually accepted. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MD.0000000000014574DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6408029PMC
February 2019
9 Reads

Prospective observational study to evaluate the efficacy and safety of the pollen extract Sérélys in the management of women with menopausal symptoms.

Gynecol Endocrinol 2019 Apr 10;35(4):360-363. Epub 2019 Feb 10.

b Exeltis Healthcare , Ismaning , Germany.

Safety concerns or contraindications to the use of hormones have resulted in a rise of the use of herbal medicinal products for the management of menopausal symptoms. The pollen extract Sérélys represents, due to its ingredients and mode of action, a new and innovative alternative for the management of these symptoms. The aim of the present study was to demonstrate the efficacy and safety of Sérélys. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/09513590.2018.1538347DOI Listing
April 2019
6 Reads

Breastfeeding reduces risk of depression later in life in the postmenopausal period: A Korean population-based study.

J Affect Disord 2019 04 25;248:13-17. Epub 2018 Dec 25.

Department of Health Convergence, Ewha Womans University, 52 Ewhayeodae-gil, Seodaemun-gu, Seoul 03760, Republic of Korea. Electronic address:

Objective: The relationship between breastfeeding and maternal depression in later life has not yet been investigated. We examined whether the number of breastfed infants or the period of breastfeeding influenced maternal depression in postmenopausal women.

Methods: We analyzed 1,372 parous postmenopausal women aged ≥ 50 years who had participated in the Korea National Health and Nutrition Examination Survey 2014. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jad.2018.12.081DOI Listing
April 2019
6 Reads

Allopregnanolone and reproductive psychiatry: an overview.

Int Rev Psychiatry 2019 05 31;31(3):237-244. Epub 2019 Jan 31.

a Department of Psychiatry & Behavioral Sciences , Women's Mood Disorders Center, Johns Hopkins University School of Medicine , Baltimore , MD , USA.

Psychiatric symptoms that coincide with reproductive transitions are related to changes in sex steroids, but studies show that this relationship is governed by individual women's vulnerability to change rather than by differences in level. There is growing interest in the role of allopregnanolone (ALLO), a 3- reduced metabolite of progesterone and a strong allosteric modulator of the GABA receptor, in such symptoms, with enough evidence now across various times of reproductive transition to offer an overview of the role of this hormone in reproductive psychiatry. This review offers a brief overview, focusing on literature of the last 3 years, of the relationship between allopregnanolone and mood at menarche; in the menstrual cycle; in the peripartum; and in the menopausal transition. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/09540261.2018.1553775DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6594874PMC
May 2019
1 Read

Alterations in Systemic and Cognitive Glucocorticoid Sensitivity in Depression.

Biol Psychiatry Cogn Neurosci Neuroimaging 2019 03 4;4(3):310-320. Epub 2018 Dec 4.

Department of Psychiatry, University of Wisconsin-Madison, Madison, Wisconsin. Electronic address:

Background: Decades of research point to cortisol insensitivity as a biomarker of depression. Despite a vast literature on cortisol's effects on memory, the role of cortisol insensitivity in core psychological features of depression, such as emotional memory biases, is unknown.

Methods: Sixty-five premenopausal women with varying levels of depression completed this study involving an at-home low-dose dexamethasone suppression test and four experimental sessions (i. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bpsc.2018.11.007DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6399042PMC
March 2019
1 Read

Sex differences in response to ketamine as a rapidly acting intervention for treatment resistant depression.

J Psychiatr Res 2019 03 8;110:166-171. Epub 2019 Jan 8.

Massachusetts General Hospital, USA.

Background: While ketamine has been increasingly studied for treatment resistant depression (TRD), the impact of sex differences on treatment outcomes has not been well studied. The objective was to ascertain whether there were differences in response to a single administration of ketamine for TRD between men and women, and between pre- and post-menopausal women.

Methods: A randomized, double-blind, placebo-controlled trial (N = 99; N = 50 male; N = 49 female) was conducted to investigate the efficacy of intravenous ketamine versus active placebo as augmentation of antidepressant therapy for TRD. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jpsychires.2019.01.010DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6360121PMC
March 2019
2 Reads

Loss of the interaction between estradiol and insulin-like growth factor I in brain endothelial cells associates to changes in mood homeostasis during peri-menopause in mice.

Aging (Albany NY) 2019 01;11(1):174-184

Cajal Institute, Madrid, Spain.

We recently reported that exercise increases resilience to stress in young female mice. Underlying mechanisms include an interaction of the ovarian hormone estradiol (E2) with insulin-like growth factor I (IGF-I), and an increase in the hippocampal levels of the latter. Since changes in mood regulation during aging may contribute to increasing incidence of affective disorders at older age, we determined whether the protective actions of exercise are maintained at later ages. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18632/aging.101739DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6339786PMC
January 2019
32 Reads

Systematic review of fertility-related psychological distress in cancer patients: Informing on an improved model of care.

Psychooncology 2019 01 20;28(1):22-30. Epub 2018 Nov 20.

School of Women and Children's Health, Faculty of Medicine, UNSW Sydney, Sydney, Australia.

Objective: Cancer patients experience reproductive concerns from diagnosis through to survivorship. However, research has yet to investigate the degree of fertility-related psychological distress at different treatment time points: diagnosis, treatment, and survivorship. Currently, cancer patients are offered fertility counselling at the time of diagnosis, to assist fertility preservation decision making. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/pon.4927DOI Listing
January 2019
37 Reads

Menstrual Cycle Hormone Changes Associated with Reproductive Aging and How They May Relate to Symptoms.

Obstet Gynecol Clin North Am 2018 Dec 25;45(4):613-628. Epub 2018 Oct 25.

Department of Obstetrics and Gynecology, University of Colorado School of Medicine, 12631 East 17th Avenue, Mail Stop B-198, Aurora, CO 80045, USA. Electronic address:

Key cycle changes occur as women transition from reproductive life to menopause, and they can be roughly linked to menopausal staging. It is important to understand the types of studies that inform the current knowledge. Patterns of symptoms within menstrual cycles (sleep, headache) generally favor worsening in association with the perimenstrual phase of the cycle, and patterns of chronic symptoms, such as hot flashes and adverse mood, appear to be worse when hormones are more variable. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ogc.2018.07.004DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6226272PMC
December 2018
8 Reads

Onset of the Menopause Transition: The Earliest Signs and Symptoms.

Obstet Gynecol Clin North Am 2018 Dec 25;45(4):585-597. Epub 2018 Oct 25.

Department of Obstetrics/Gynecology, University of Pennsylvania School of Medicine, 3400 Spruce Street, Philadelphia, PA 19104, USA; Department of Psychiatry, University of Pennsylvania School of Medicine, 3400 Spruce Street, Philadelphia, PA 19104, USA.

Although more than 80% of women experience some degree of psychological or physical symptoms around menopause, both women and clinicians have misconceptions about how hormonal changes relate to menopausal symptoms and psychological conditions. Recently, several large-scale, longitudinal studies have been conducted to better characterize symptoms and changes that occur around menopause. This article offers current evidence for symptoms that occur in the early menopause transition, including vasomotor symptoms, mood changes, sleep problems, and changes in sexual functioning. Read More

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S08898545183006
Publisher Site
http://dx.doi.org/10.1016/j.ogc.2018.07.002DOI Listing
December 2018
44 Reads

Menopause.

Prim Care 2018 Dec 5;45(4):625-641. Epub 2018 Oct 5.

Department of Family Medicine and Community Health, University of Wisconsin School of Medicine and Public Health, 1100 Delaplaine, Madison, WI 53715, USA.

The menopausal transition is a time when many physical and psychological changes are occurring for women. Women may experience irregular menses, vasomotor symptoms, sleep disruption, mood disorders as well as genitourinary symptoms. Despite irregular menstrual cycles, some women can still conceive. Read More

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S00954543183007
Publisher Site
http://dx.doi.org/10.1016/j.pop.2018.08.001DOI Listing
December 2018
35 Reads

Investigating the relationship between psychological hardiness and resilience with depression in women with breast cancer.

Gulf J Oncolog 2018 Sep;1(28):23-30

School of Health, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.

Introduction: Considering the fact that depression in patients with breast cancer increases the severity and complications of medical treatments such as chemotherapy (including fatigue, nausea, and cognitive problems), the identification of its related factors can be one of the important steps in reducing the complications of this disease. Therefore, the purpose of this study was to determine the relationship between psychological hardiness and resilience with depression in women with breast cancer.

Materials And Methods: The present study was a descriptive-analytic study, the population of which included all women with breast cancer under chemotherapy referred to Oncology Center of Imam Hassan Mojtaba Hospital in Dezful city from July 2015 to December 2016. Read More

View Article

Download full-text PDF

Source
September 2018
2 Reads

The association between exposure to second-hand smoke and major depressive disorder in perimenopausal women: results from apopulation-based study.

Ann Med 2018 11 19;50(7):596-604. Epub 2018 Nov 19.

b School of Medicine , Chang Gung University , Taoyuan , Taiwan.

Purpose: The aim of this study was to test the hypothesis that exposure to second-hand smoke (SHS) would be positively associated with major depressive disorder (MDD) in perimenopausal women from a population-based perspective, after adjustment for all potential confounders.

Methods: This study used the National Health and Nutrition Examination Survey (NHANES) database, 2005-2012, to report on MDD in perimenopausal women.

Results: The odds ratio (OR) for MDD increased when there was a smoker was in the home, as compared to not having a smoker in the home (aOR = 2. Read More

View Article

Download full-text PDF

Source
https://www.tandfonline.com/doi/full/10.1080/07853890.2018.1
Publisher Site
http://dx.doi.org/10.1080/07853890.2018.1534264DOI Listing
November 2018
5 Reads